
Treatment Emergent Symptom Scale (TESS) was developed by The National Institute of Mental Health (NIMH) in the USA in 1973. It is a safety assessment tool after treatment of psychiatric diseases. We will use it to evaluate participants' adverse reactions at a time point of 2 weeks, 1 month, and 3 months.
Full
AnswerAll Answers (2)
please refer to following reference for TESS, National Institute of Mental Health. 1985d. TESS (Treatment emergent symptoms scale). Psychopharmacol
Similar questions and discussions
What is proper effect size measure for a general linear model with a gamma distribution and log link?
